Superworth

Verastem profit margin VSTM

Gross, operating and net profit as a share of revenue over the last twelve months, from 2020.

Net margin, 12 months
n/m
not a meaningful number
Peer median
22.5%

Verastem's net margin works out at −232% over the last twelve months, but it is not a meaningful number: a margin outside minus 100% to 100% is moved by items that are not sales.

Profit margin over time

GrossOperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating marginGross margin
FY2025n/an/an/a
FY2024n/an/an/a
FY2023n/an/an/a
FY2022n/an/an/a
FY2021n/an/an/a
FY2020−76.5%−55.8%98.0%
FY2019n/an/a92.9%
FY2018n/an/an/a
FY2017n/an/an/a
FY2016n/an/an/a
FY2015n/an/an/a
FY2014n/an/an/a
FY2013n/an/an/a
FY2012n/an/an/a
FY2011n/an/an/a

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a year
Q2 FY26n/an/a
Q1 FY26n/an/a
Q4 FY25n/an/a
Q3 FY25n/an/a
Q2 FY25n/an/a
Q1 FY25n/an/a
Q4 FY24n/an/a
Q3 FY24n/an/a
Q2 FY24n/an/a
Q1 FY24n/an/a
Q4 FY23n/an/a
Q3 FY23n/an/a

Against its peers

Companies in Drug Manufacturers - General nearest Verastem's size, closest first, today.

CompanyProfit margin
VSTMVerastemn/m
ABUSArbutus Biopharma84.2%
AMPHAmphastar Pharmaceuticals10.8%
COLLCollegium Pharmaceutical5.9%
OMEROmerosn/m
CRMDCorMedix40.5%
ZVRAZevra Therapeutics42.8%
IRWDIronwood Pharmaceuticals33.4%
PCRXPacira BioSciences2.0%
PBYIPuma Biotechnology11.6%
ANABAnaptysbion/m
Peer median22.5%

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Verastem

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.